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Abstract
In this study we report that, in response to proteasome inhibition, the E3-Ubiquitin ligase TRIM50 localizes to and promotes
the recruitment and aggregation of polyubiquitinated proteins to the aggresome. Using Hdac6-deficient mouse embryo
fibroblasts (MEF) we show that this localization is mediated by the histone deacetylase 6, HDAC6. Whereas Trim50-deficient
MEFs allow pinpointing that the TRIM50 ubiquitin-ligase regulates the clearance of polyubiquitinated proteins localized to
the aggresome. Finally we demonstrate that TRIM50 colocalizes, interacts with and increases the level of p62, a
multifunctional adaptor protein implicated in various cellular processes including the autophagy clearance of
polyubiquitinated protein aggregates. We speculate that when the proteasome activity is impaired, TRIM50 fails to drive
its substrates to the proteasome-mediated degradation, and promotes their storage in the aggresome for successive
clearance.
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Introduction
The ubiquitin proteasome system (UPS) is a highly conserved
pathway that removes non-functional, damaged, and/or misfolded
proteins from the cell. However, when the capacity of the
proteasome is impaired, misfolded proteins cannot be properly
cleared and they accumulate into the aggresome [1,2], an
inclusion body localized in the proximity of the microtubule-
organizing centre (MTOC) [3,4]. Microtubule-associated histone
deacetylase 6 (HDAC6) mediates this process [5]. Through its
ubiquitin-binding BUZ finger domain, HDAC6 binds to and
facilitates the transport of polyubiquitinated misfolded proteins
along microtubules to aggresome [2]. Aggresome clearance is
mediated by ubiquitin-binding proteins like p62/SQSTM1 and
NBR1 [6]. These adaptor proteins through their ubiquitin-binding
domain (UBA) decide the fate of protein degradation either
through UPS or autophagy-lysosome pathway [6,7,8]. Ubiquitin
ligases are terminal enzyme in the process of ubiquitination, which
provides specificity to the pathway by recognizing the substrates.
Experimental evidences suggest that E3-Ubiquitin ligases play an
important role also in the execution of autophagy [9,10].
Therefore searching for new E3-Ubiquitin ligases involved in
such processes are of interest.
TRIM proteins are RING E3-Ubiquitin ligases defined by
the presence of a tripartite motif consisting of a RING, one or
two B-Box, and a Coiled-Coil domain involved in a variety of
cellular processes, including regulation of cell cycle progression,
differentiation, development, oncogenesis, and apoptosis
[11,12,13]. TRIM50 is one of 28 hemizygous genes mapping
to the region rearranged in Williams Beuren syndrome (WBS)
[14,15], a genomic disorder characterized by mental retardation
and multiple dysmorphic and metabolic features [16]. TRIM50
encodes an E3-Ubiquitin ligase that self-associates to form
cytoplasmic bodies in the cell, like other TRIM proteins
[13,15]. The nature and role of these bodies as well as the
cellular function of TRIM50 is just beginning to emerge [15].
Here we report that TRIM50 cytoplasmic bodies are aggresome
precursors. We show that during proteasome impairment
TRIM50 promotes the recruitment and aggregation of poly-
ubiquitinated proteins to the aggresome, and participates to
aggresome clearance. In addition we identified two novel
TRIM50 protein interactors, HDAC6 and p62, and show that
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TRIM50 determines the accumulation of both p62 and
HDCA6 into an insoluble protein aggregate fraction.
Results
TRIM50 Localizes to Cytoplasmic Bodies
We previously reported that ectopically expressed TRIM50
localizes mainly into discrete cytoplasmic punctuate structures
heterogeneous in size and shape, with the intact central region of
the protein (B-Box and Coiled-Coil domains) indispensable for the
proper localization [15]. To rule out that the observed pattern was
due to TRIM50 overexpression, we showed that also the
endogenous TRIM50 localizes in diffuse cytoplasmic round bodies
in human neuroblastoma-derived SH-SY5Y cell lines (Figure 1A).
Ectopically expressed TRIM50 cytoplasmic bodies did not
associate with known cellular compartments and markers includ-
ing trans- and cis-Golgi, endosomes, caveolae, vesicles, lysosomes,
cytosckeletal structures, peroxisomes, stress granules, and P-bodies
(Figure S1).
Using live microscopy, we showed that ectopically expressed
TRIM50 cytoplasmic bodies are highly motile structures varying
in size and shape that exhibit multidirectional short and fast
jumping movements and able to assemble larger cytoplasmic
bodies from smaller particles (Figure S2A–B, and Movie S1). To
gain insight into the dynamics of TRIM50 bodies, we performed
Fluorescence Recovery After Photobleaching (FRAP) [17]. Our
analysis revealed that the fluorescence of a photobleached
cytoplasmic body significantly recovers within the 2 min of the
time-period experiment (Fig. S2C, and Movie S2). The FRAP
data confirm that TRIM50 cytoplasmic bodies are dynamic,
rapidly exchanging between different cytoplasmic regions, and
promptly turned over.
Further characterization of TRIM50 bodies was achieved by
Correlative Light-Electron Microscopy (CLEM). This analysis
revealed that the fluorescent bodies corresponded to heteroge-
neous in morphology TRIM50-containing protein aggregates,
confirming their tendency to self-associate into larger structures
(Figure S2D).
TRIM50 Associates with Aggresome
We asked whether TRIM50 bodies associate with aggresome.
In SH-SY5Y cells, treated with the proteasome inhibitor MG132
and stained with FK2, which recognizes polyubiquitinated
proteins, endogenous TRIM50 concentrated close to a perinuclear
structure whose morphology and localization resemble that of
aggresome (Figure S3A, d–f). To further investigate the possible
link between TRIM50 and aggresome, we used HDAC6, an
established aggresome marker [18]. We found that both endog-
enous and transfected TRIM50 partially located with HDAC6
under proteasome inhibition (Figure 1B, d–f; Figure S3B, d–f).
This cellular localization does not depend on the E3-ligase activity
of the RING domain of TRIM50 as a mutant lacking the RING
domain retains the ability to localize to aggresome (Figure S4A).
In accordance with the central role of retrograde microtu-
bule-dependent transport in the formation of aggresome,
nocodazole treatment of SH-SY5Y cells prevented the localiza-
tion of TRIM50 to aggresome (data not shown). In agreement
we demonstrated that TRIM50 interacts with Tubulin beta 2B
class IIb (Tubb2b) (NM_178012.4), a microtubules component
(Figure S3C). Together these findings suggest that TRIM50
bodies may represent aggresome precursors that in response to
proteasome inhibition move towards aggresome by a microtu-
bule dependent transport.
To assess whether HDAC6 is required for the proper
localization of TRIM50, we performed immunofluorescence
assays in Hdac6 deficient mouse fibroblasts [19]. We found that
in Hdac6 wild-type cells, Trim50 bodies localize within FK2-
ubiquitin-containing aggresomes upon MG132 treatment
(Figure 1C, d–f). Conversely, when MG132 was added to Hdac6
knock out cells Trim50 bodies were unable to form whole
aggresome, although they still continued to partially colocalize
with ubiquitinated aggregates (Figure 1C, j–l). These results
indicate that HDAC6 is required for the proper localization of
TRIM50 bodies and of ubiquitinated proteins within the
aggresome. We then investigated whether the observed
TRIM50-HDAC6 colocalization results also in their physical
interaction. As no anti-TRIM50 antibodies are actually effective
for immunoprecipitation assays, we generated a HEK293 cell line
that stably expresses a FLAG-tagged TRIM50 (hereafter referred
to as FLAG-TRIM50#3). As shown in Figure 2A, TRIM50
interacts with endogenous HDAC6; an interaction that strength-
ens in response to MG132 treatment (compare lane 1 to lane 2 in
Figure 2A).
TRIM50 Interacts with p62
Proteomics assays were designed to identify novel TRIM50
partners. TRIM50 complexes were isolated by immunoprecipita-
tion of total protein lysate from FLAG-TRIM50#3 cells and
individual protein components were solved and identified by nano
LC-MS/MS. Among the putative TRIM50 interactors, we
focused on p62 (also known as Sequestosome 1/p62), because of
its involvement in the formation of protein aggregates [20], its role
as shuttling factor for the delivery of polyubiquitinated substrates
to the proteasome [21], and for emerging central importance at
the intersection of proteasome and autophagy pathways [22]. First
we assessed whether TRIM50 and p62 self associate. FLAG-
TRIM50#3 cells was transfected with a plasmid that expresses
Myc-tagged p62. Total cell lysates were then immunoprecipitated
with an anti-FLAG and immunoblotted with an anti-Myc specific
antibody. An anti-Myc reactive band was exclusively precipitated
in the presence of FLAG-TRIM50 (Figure 2C, left side).
Consistently, we detected FLAG-TRIM50 in protein lysates
immunoprecipitated with an anti-Myc and immunoblotted with
an anti-FLAG antibody (Figure 2C, right side), substantiating the
interaction between TRIM50 and p62.
Next, to map the TRIM50 domain(s) involved in p62
interaction, we used a set of FLAG-TRIM50 mutants [15]
(Figure 2B). Upon co-transfection with Myc-p62 and coimmuno-
precipitation with an anti-FLAG, we found that both coiled coil
domains of TRIM50 are required for the efficient binding of p62
(Figure 2D). Likewise, to define the p62 interaction region, we
performed co-immunoprecipitation and GST pull down assays
using p62 deletion mutants (Figure 3A). As reported in Figure 3B
and 3C we narrowed the p62 interaction region between
aminoacids 302–370, a region that includes the LC3 binding
region [23].
Figure 1. TRIM50 bodies colocalize into aggresome by a Hdac6-dependent way. (A) SH-SY5Y cells were stained with anti-TRIM50 antibody.
(B) SH-SY5Y cells were stained with anti-TRIM50 and anti-HDAC6 antibodies. The cells were treated with 25 mM MG132 for 6 h (d,e,f). (C) Hdac6 wild
type and Hdac6 deficient mouse fibroblasts were transfected with EGFP-Trim50 followed by treatment with 25 mM MG132 for 6 h where indicated,
and immunostained with FK2 antibody.
doi:10.1371/journal.pone.0040440.g001
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TRIM50 Promotes the Sequestration of Ubiquitinated
Proteins into Aggresome and Drives the Accumulation of
p62 and HDAC6
We investigated whether TRIM50 and p62 colocalize into the
aggresome. First, by fluorescence microscopy we showed that p62
colocalizes with HDAC6 upon MG132 treatment (Figure 4A).
Then we found a partial colocalization between endogenous p62
and TRIM50 in SH-SY5Y cells (Figure 4B, a–c), which was
intensified in presence of MG132 (Figure 4B, d–f).
Next we asked whether TRIM50 has any role in the
recruitment and/or accumulation of polyubiquitinated proteins
to the aggresome. MG132 treatment resulted in a prominent
accumulation of higher-molecular-weight species constituted by
polyubiquitinated proteins in the detergent insoluble fraction as
showed by immunoblot with an anti-ubiquitin antibody
(Figure 4C). These data were confirmed in Trim50 deficient
mouse embryo fibroblasts (kindly provided by Prof. Reymond).
Depletion of endogenous Trim50 resulted in a decrease of
polyubiquitinated protein levels in MG132 treated cells (compare
lane 4 to 8 in Figure 4D). We then examined whether the
TRIM50 depletion influences the area, perimeter, and intensity
of FK2-polyubiquitinated dots. MEF Trim502/2 cells showed a
significant decrease of signal intensity, compared to the wild type
and heterozygous counterpart, while no significant difference was
observed for the area and size of the dots (Figure 5A). Notably,
MEF Trim502/2 cells treated with MG132 showed a highly
significant reduction of all three parameters compared to the wild
type and heterozygous mouse cell lines, respectively (Figure 5B).
Since the aggregates formation is a reversible process, to explore
the effect of TRIM50 on the clearance of aggresome components,
we analyzed the aggresome insolvency. MG132-pretreated MEF
Trim50 cells were incubated in a free-drug media for 48 h, and the
FK2-aggresome positive cells were counted. Immediately after the
removal of MG132, we found a significant decrease of the number
of FK2-positive aggregates in Trim502/2 cells compared to the
Trim50+/+ (Figure 5C). More interestingly, 48 hours after the
MG132 removal we observed a significantly higher number of
FK2-positive aggregates in MEF Trim502/2 compared to MEF
Trim50+/+ suggesting that Trim50 is required for the clearance of
polyubiquitinated proteins included within aggresome (p = 0.03,
Figure 5C). Thus our analysis suggests that TRIM50 plays an
active role in the sequestration of polyubiquitinated proteins in the
aggresome.
Finally, we assessed whether TRIM50 overexpression has any
effect on protein level of the endogenous HDAC6 and p62. p62
protein enrichment was observed in both soluble and insoluble
fractions upon TRIM50 overexpression in the presence of MG132
(Figure S5A–B). Likewise we observed an increase of HDAC6
protein amount in both fractions, mainly upon MG132 treatment
(Figure S5C). These results demonstrate that TRIM50 promotes
the accumulation of both p62 and HDCA6, particularly into
detergent insoluble aggregates.
Inhibition of Lysosomal Activity Results in TRIM50
Accumulation and Increases the Number of TRIM50-
positive Bodies
To evaluate the role of the autophagy in the turnover of
TRIM50, we measured the amount of TRIM50 protein level in
cells treated or not with the lysosomal enzyme inhibitor
ammonium chloride (NH4Cl) (Figure 6A–B). Compared with
DMSO treated-cells, treatment with NH4Cl resulted in about 5
fold-increases in TRIM50 levels over time. Moreover we
monitored the subcellular localization of TRIM50 cytoplasmic
bodies after induction and inhibition of autophagic flux. In cells
treated with NH4Cl, we observed a slight but clear increase in the
number of intracellular TRIM50 positive bodies (Figure 6 C).
Notably, FK2 positive proteins lose their colocalization with
TRIM50 bodies after the inhibition of autophagic flux. These data
suggested that TRIM50 itself and TRIM50-related bodies might
be mainly degraded by autophagy-lysosomal pathway.
Discussion
In this study we showed that the E3 ubiquitin ligase TRIM50
forms highly dynamic and heterogeneous cytoplasmic bodies
containing polyubiquitinated proteins. Inhibition of proteasome
activity resulted in the coalescence of TRIM50 bodies into
aggresome and in their colocalization with HDCA6 protein; this
localization does not depend on the E3 ubiquitin ligase activity of
TRIM50. Using fibroblast from Hdac6-deficient mice, we demon-
strated that the TRIM50 aggresome localization is HDAC6-
dependent. Importantly, in the presence of MG132, we observed
that TRIM50 bodies change their shape in absence of HDAC6,
becoming larger and lost the localization into the aggresome.
Overall these evidences demonstrated that the TRIM50 inclusion
bodies are aggresome precursors. Evidence that the TRIM50
localization is not merely artifact of overexpression comes from
experiment in which the endogenous TRIM50 displayed a very
similar localization to that of transfected protein (Figure 1B and
S3B). Importantly this study demonstrated that TRIM50 is a novel
component of and promotes the accumulation of ubiquitinated
substrates to aggresome. Moreover we identified two novel
TRIM50 partners, HDAC6 and p62, both involved in the
clearance of polyubiquitinated and misfolded protein aggregates
[2,3,4,24].
The composition of the aggresome was partially solved by mass
spectrometry [25,26]. Song and colleagues showed that the higher
proportion of aggresome-enriched proteins is related to molecular
chaperones and ubiquitin-proteasome system components, in-
volved in the elimination of misfolded and/or ubiquitinated
proteins from cells [27]. Notably, a number of TRIM50
interactors that we have isolated in our proteomics approach,
have been identified in a recent screening of proteins associated
with MG132-induced aggresome in SH-SY5Y cells [26]. Among
them are proteins known to interact with misfolded proteins and
play a role in protein aggregation [28] including p62, chaperone
proteins like Serpin H1, HSP90B1, PPIB, and 14-3-3 (eta and
zeta) (Table S2). Moreover a number of the TRIM50-bound
Figure 2. TRIM50 interacts with HDAC6 and p62. (A) The interaction between TRIM50 and HDAC6 was assayed in HEK293 FLAG-TRIM50#3 cell
line, treated with MG132. The cell lysates were immunoprecipitated (IP) with anti-FLAG and Immunoblot (IB) with HDAC6 antibody. Asterisk indicate
IgG aspecific band. (B) Schematic representation of TRIM50 deletion mutants used, with the minimal TRIM50 interaction region. (C) The interaction
between TRIM50 and p62 was assayed in FLAG-TRIM50#3 transfected with Myc-p62. The cell lysates were immunoprecipitated with anti-FLAG (left)
and with anti-Myc (right) antibodies, respectively. Immunoblot were done as indicated (asterisk indicates FLAG-TRIM50 coming from the first FLAG
blotting). (D) Total lysates of HEK293 cells transfected both with TRIM50 deletion mutants and Myc-p62 were immunoprecipitated with anti-FLAG and
immunoblotted with anti-Myc.
doi:10.1371/journal.pone.0040440.g002
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Figure 3. p62 deletion mutants interacting with TRIM50. (A) Schematic representation of p62 deletion mutants with the minimal region of
interaction with TRIM50. Lysates from FLAG-TRIM50#3 expressing a number of p62 deletion mutants were immunoprecipitated with anti-FLAG and
immunoblotted with anti-GFP (B) and anti-GST (C).
doi:10.1371/journal.pone.0040440.g003
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proteins were found ubiquitinated in previous studies [29,30] or
annotated in the Ubiprot database [31] (Table S2). Overall these
data give additional evidences that TRIM50 bodies are aggresome
precursors involved in the ubiquitination and aggregation process
of misfolded proteins.
We confirmed the interaction of TRIM50 with p62. p62 is a
multifunctional adapter protein implicated in autophagy, cell
signaling, receptor internalization, inflammation and protein
turnover [22]. p62 is found in cytosolic protein aggregates that
accumulate in various chronic, toxic, and degenerative diseases. It
interacts with ubiquitinated proteins carrying them on the road to
autophagy-mediated degradation [23,32]. The TRIM50-p62
interacting region involves amino acids 302–370, a region that
includes the LC3-Interacting Region (LIR) domain involved in the
binding to LC3 (microtubule-associated protein 1A/1B light chain
3) [23] a modifier protein that plays a pivotal role in autophago-
some biogenesis [33]. Interestingly we have some preliminary data
showing that TRIM50 and LC3 colocalize in both normal and
autophagy-induced conditions (Figure S4B and Fusco, unpub-
lished results). Moreover using the NH4Cl autophagy inhibitor, we
found that TRIM50 is partially degraded through the autophagy-
lysosomal pathway (Figure 6). However how this degradation
occurs remains yet unclear; one possibility is that TRIM50 could
directly associate with LC3, or that TRIM50 could be addressed
together with p62 to autophagy machinery for its degradation. In
that way the observed colocalization between TRIM50 and LC3 is
intriguing and deserves more investigations. These findings suggest
also that p62 may serve as a scaffold protein, via the interaction
with TRIM50, whereby chains of polyubiquitin are transferred to
target substrates for degradation. Nevertheless it is tempting to
speculate that TRIM50 might be involved in autophagy processes
as well.
Increasing evidences indicate that autophagy-related proteins
are sequestrated into the aggresome as a selective mechanism to
regulate their degradation [24]. Since aggresome formation
mainly takes place in the insoluble fraction [34,35] we assessed
whether TRIM50 has a role in the accumulation of polyubiqui-
tinted proteins. We observed that TRIM50 promotes the
recruitment of polyubiquitinated proteins to aggresome and that
the observed decrease of aggresome clearance was associated to
the depletion of TRIM50 (Figure 5C), suggesting that these
proteins are TRIM50 substrates.
Overall the data reported in this study reveal a role for TRIM50
in aggresome formation and add further insights on its function by
identifying and characterizing its first two protein partners. We
speculate that, when the proteasome activity is impaired, TRIM50
ensures the sequestration of its targets to the aggresome via the
association with HDAC6 and their subsequent likely removal by
p62-mediated autophagy. Further studies, particularly the identi-
fication of TRIM50 specific substrates, are needed to unequivo-
cally assess the authenticity of this model.
Accumulation of polyubiquitinated protein aggregates is a
hallmark of several neurodegenerative disorders as well as of a
number of other protein aggregation diseases affecting muscles,
heart, liver and lung [36,37]. p62 has been identified as a
component of inclusion bodies in several human diseases, such as
neurodegenerative diseases (e.g., Alzheimer’s disease, Parkinson’s
disease, and amyotrophic lateral sclerosis) and in liver diseases
(e.g., alcoholic hepatitis, hepatic steatosis, and hepatocellular
carcinoma) [38]. It will hence be interesting to investigate whether
TRIM50 is also a component of such bodies and it could even be
responsible for targeting p62 to these sites.
Materials and Methods
Fusion Plasmids
The pcDNA3-EGFP and pCDNA3-HA wild-type and mutants
TRIM50 were described in [15]. Human b2-tubulin ORF was
cloned into a pcDNA3 vector with FLAG as tag using a PCR
based method with appropriate oligonucleotides followed by in-
frame insertion into the vector. DsRED -LC3 and pENTR-EGFP,
GST tagged p62 and GST-p62 mutants were a kind gift from Prof.
T. Johansen (Institute of Medical Biology, University of Tromso,
Norway), pcDNA3-Myc-p62 was a generous gift of Prof. Marie W.
Wooten (Cellular and Molecular Biosciences Program, Auburn
University, USA). pcDNA3-HA-HDAC6 mutants were a gift of
Prof. Matthias (Friedrich Miescher Institute for Biomedical
Research, Basel, Switzerland). The plasmids used in this study
are listed in Table S1.
Cell Culture and Stable Cell Line Production
HEK293, HeLa cells, SH-SY5Y (all from ATCC, Manassas,
USA), and MEF were maintained in DMEM with Glutamax
medium supplemented with 10% fetal bovine serum and 1%
antibiotics (Invitrogen, Carlsbad, CA). Hdac6 MEF (mouse
embryo fibroblast) cells were kindly provided by Prof. Joo-Yong
Lee (Duke University, Durham, USA) [39].
Fugene 6 (Roche) was used for transfection according to the
manufacturers’ instructions. HEK293 were transfected with
pcDNA3-FLAG-TRIM50 or empty vector and selected for 2
weeks with 1 mg/ml G418 (Invitrogen, Carlsbad, CA) selective
agent. The expressing colonies were expanded and then used for
protein extract preparations following standard procedures.
HEK293 cell line was used since the low level expression of
endogenous TRIM50 protein.
Hereafter the stable cell lines will be referred to as FLAG-
TRIM50#3 and FLAG#3, respectively.
Mouse Embryo Fibroblast Generation
To identify loss-of-function mutation in Trim50, we screened the
sequence of the first exon of this gene in the sperm DNA archives
of F1 male progeny of ENU-treated (ethylnitrosourea) males and
untreated females established by INGENIUM (http://www.
ingenium-ag.com). We identified two missense (V55M and
V60G) and one nonsense mutation. The latter mutation creates
a premature stop codon by modifying TGC into a TGA amber
codon. This C52X mutation in the middle of the RING domain
abrogates the E3-ligase activity of Trim50, as the next in frame
methionine residue is situated in the coiled-coil domain after both
the RING and the B-box type 2 of the Trim50-encoded protein.
We recovered the nonsense mutant mouse from the frozen archive
using in vitro fertilization. Due to the generation method, the first
Figure 4. TRIM50 colocalizes with p62 into aggresome. (A) SH-SY5Y cells were stained with anti-HDAC6 and with anti-p62 antibodies. The cells
were treated with 25 mM MG132 for 6 h (d,e,f). (B) SH-SY5Y cells were stained with anti-TRIM50 and anti-p62 antibodies. The cells were treated with
25 mM MG132 for 6 h (d,e,f). (C) Lysates from FLAG-TRIM50#3 and FLAG#3 cell lines, treated with vehicle (–) or MG132 (+) were separated in RIPA
detergent-soluble (S) and detergent insoluble (I) fractions and immunoblotting with anti-FLAG and anti-ubiquitin antibodies. (D) Lysates from MEF
Trim50 cell lines with different genotype (+/+,2/2), treated with vehicle (–) or MG132 (+) were separated in RIPA detergent-soluble (S) and detergent
insoluble (I) fractions, analyzed by Western Blot and immunoblotting with anti-ubiquitin antibody.
doi:10.1371/journal.pone.0040440.g004
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heterozygote mice (F1) have around twenty ‘‘background’’
mutations in addition to the wanted one. They were backcrossed
with C3HeB/FeJ wild-type mice from Jackson laboratories for 12
generations to purge the strain of other mutations potentially
induced by the ENU treatment. Mouse embryonic fibroblasts
(MEFs) were prepared from E13.5 embryos as described in [40].
Cells were subsequently genotyped by Sanger sequencing to
identify +/+, +/2 and 2/2 lines. All procedures used with mice
models and to generate the MEFs were approved by the CIG
Institutional Animal Care and followed the National Institutes of
Health Guidelines, ‘Using Animals in Intramural Research’. The
work was approved by the ethics committee of the Veterinarian
Cantonal Office (authorization Vaud-1958).
Immunofluorescence Microscopy
For immunofluorescence analyses, the cells transfected with
EGFP-TRIM50 were fixed before their incubation with the
primary and secondary antibodies of interest, mounted in mowiol
and examined on a Zeiss LSM 510 META confocal microscope
(Carl Zeiss, Jena, Germany). All confocal images were obtained
using the necessary filter sets for GFP, Alexafluor 488 and 546,
using a Zeiss Plan-Neofluor 636oil immersion objective (NA 1.4),
with the pinhole set to one Airey unit.
Live Cell Imaging and Fluorescent Recovery After
Photobleaching (FRAP) Analyses
HeLa cells were transfected with EGFP-TRIM50 construct and
observed at 37uC in 20mM HEPES buffered DMEM using a Zeiss
LSM 510 META confocal microscope (Carl Zeiss, Jena,
Germany). Temperature was controlled with a Nevtek air stream
stage incubator (Burnsville, VA, USA) and images of live cells were
acquired using sequential excitation at 488 nm and 543 nm. The
tracking of moving objects and evaluation of their speed were
performed using the Tracking macro of the ImageJ program.
Selective photobleaching in the regions of interest within the cell
was carried out on the Zeiss LSM510 using 100 iterations with a
488 nm laser line at full power.
Correlative Light Electron Microscopy (CLEM)
EGFP-TRIM50 transfected HeLa cells were grown on
CELLocate coverslips with coordinated grid and then prepared
for CLEM microscopy identification of TRIM50 structures
according to Polishchuk et al. [41]. Briefly, after visualization of
EGFP-TRIM50 positive bodies by time-lapse confocal microsco-
py, the cells were fixed, labeled with an antibody against EGFP
using the gold-enhance protocol, embedded in Epon-812, and cut
in serial sections. Then region containing TRIM50-positive bodies
were analyzed in serial thin sections under a Philips Tecnai-12
electron microscope (Philips, Einhoven, The Netherlands). EM
images were acquired from the region of interest using an Ultra
View CCD digital camera (Soft Imaging Systems, Munich,
Germany).
Statistical Analysis
All microscopy experiments were performed in triplicate.
Approximately 40 cells were analyzed for each experimental
condition. For the immunofluorescence experiments on Trim50-
MEF cells, area, perimeter, and intensity of FK2-positive dots
were measured using ImageJ program. The threshold was set to a
level that excludes all the cytosolic background, thus allowing
selective analysis of intense puncta representing the FK2-positive
dots. Data were reported as median along with the upper and
lower quartiles (Q1–Q3). Normal distribution assumption was
checked by means of Q-Q plot, Shapiro-Wilks and Kolmogorov-
Smirnov tests. The followed parameters were log transformed
before statistical analyses because of their skewed distribution.
Comparisons between wild-type, heterozygous and knockout mice
were assessed by means of specific contrasts defined into a
hierarchical linear model (HLM), accounting for clustering due to
multiple measures collected within cell. All p-values were adjusted
for multiple comparison following Tukey-Kramer’s method. A p-
value ,0.05 was considered for statistical significance. All
statistical analyses and graphs were performed using SAS Release
9.1 (SAS Institute, Cary, NC, USA) and R (version 2.10.1)
software, respectively.
Protein Identification by Mass Spectrometry Analysis
TRIM50 complexes were isolated from HEK293 cells total
extracts by immunoprecipitation. FLAG-TRIM50#3 and
FLAG#3 cell lines were lysed in PBS, 0.5% NP-40, 1 mM
PMSF, and COMPLETE protease inhibitors (Roche) for 45 min
under gently mixed. Total protein extracts were pre-cleared with
unspecific Mouse IgG Agarose Beads (Sigma) overnight in lysis
buffer. The protein extracts were recovered by centrifugation
(3000 rpm for 5 min) and then incubated overnight, under gently
agitation, onto M2 anti-FLAG agarose-conjugated antibody beads
(Sigma) previously blocked with no fat milk treatment. Unbound
proteins were discarded and the beads were collected by
centrifugation and extensively washed with lysis buffer supple-
mented with 150 mM NaCl to eliminate non-specific bound
proteins. Elution of the desired protein complexes was performed
by competition with FLAG peptide in elution buffer. The eluted
proteins were precipitated in methanol/chloroform and then
loaded onto a 10% SDS-PAGE. The gel was stained with colloidal
Coomassie blue (Pierce). Protein bands were excised from the gel,
reduced, alkylated and digested with trypsin as described
elsewhere (Zito et al., 2007). Peptide mixtures extracted from the
gel were analyzed by nano-chromatography tandem mass
spectrometry (nanoLC–MS/MS) on a CHIP MS Ion Trap
XCT Ultra equipped with a capillary 1100 HPLC system and a
chip cube (Agilent Technologies, Palo Alto, CA). Peptide analysis
was performed using data-dependent acquisition of one MS scan
(mass range from 400 to 2000 m/z) followed by MS/MS scans of
the three most abundant ions in each MS scan. Raw data from
nanoLC–MS/MS analyses were employed to query a non-
redundant protein database using in house MASCOT software
(Matrix Science, Boston, USA).
Immunoprecipitation, GST Pull-down and Western Blot
Co-immunoprecipitation experiments were performed as pre-
viously described [42]. Complexes were analyzed by western
blotting using indicated antibodies. Horseradish peroxidase
Figure 5. TRIM50 promotes the accumulation of polyubiquitinated proteins into the aggresome. (A) MEF Trim50 cell lines were stained
with anti-FK2 antibody. The area, perimeter and intensity of signal of three independent experiments of each genotype were estimated using imageJ
program. (B) MEF Trim50 cell lines were treated with 10 mM MG132 over night and stained with anti-FK2 antibody. The area, perimeter and intensity
of signal of three independent experiments of each genotype were estimated using imageJ program. (C) MEF Trim50 cell lines were treated with
10 mM MG132 over night, incubated o and 48 h with DMEM after MG132 wash out and stained with anti-FK2 antibody. The diagram shows the
percentage of aggresome-positive cells.
doi:10.1371/journal.pone.0040440.g005
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conjugated anti-mouse and anti-rabbit antibodies (GE Healthcare)
and the ECL chemiluminescence system (GE Healthcare) was
used for detection. Where indicated the MG132 proteasome
inhibitor (Calbiochem, USA) was added. GST-p62 (231–385) and
GST-p62 (232–370) fusion proteins were purified using glutathi-
one-Sepharose 4B beads (GE Healthcare) according to the
manufacturer’s instructions. For the GST pulldown assay, 3 mg
of GST-recombinant proteins were mixed with 40 mg of total
FLAG-TRIM50#3 cell lysate and incubated at 4uC for 2 h with
rotation, and then incubated with FLAG antibody for 4 h. The
binding fraction was washed four times and then loaded into a
SDS 10% PAGE gel, and immunoblotted with anti-GST antibody
(Santa Cruz). Soluble and insoluble fractions were obtained using
RIPA buffer as described elsewhere (Muqit et al., 2006). Protein
band densities were determined using densitometer (Kodak). The
amount of the protein was calculated by the initial amount of
FLAG-protein level and normalized with GAPDH. Cells treated
with DMSO were used as control.
Supporting Information
Figure S1 TRIM50 does not colocalize with known and
induced cellular organelles. (A) HeLa cells were transiently
transfected with EGFP-TRIM50, fixed and stained for different
cytoplasmic markers. The panel shows the merge of EGFP-
TRIM50 (green) with single marker (red): Golgi markers (a,b,c,d,i),
early endosomes (e), the coat complex of endoplasmic reticulum
associated vesicles (f,g,h), lysosomes (j), cytoskeletal structures (k),
and peroxisomes (l). (B) HeLa cells were transiently transfected
with EGFP-TRIM50. After 24h the cells were cultured in presence
of arsenite (0.5 mM for 30 min.) before processed and immuno-
stained with anti-Eif3 for stress granules (b,c), and anti-HuR for P-
bodies (e,f).
(TIF)
Figure S2 Movement of TRIM50 particles and determi-
nation of the movement rates. (A) HeLa cells transiently
expressing EGFP-TRIM50 were imaged over 110 frames at
0.5 sec intervals. The individual frames were summed using
ImageJ. The tracks of three single particles are shown (blue,
particle a; green, particle b; red, particle c). The asterisks indicate
starting point of each particle. (B) Velocities of particles a–c were
measured throughout the time that they were observed during the
frames by using manual tracking plugin of ImageJ program. The
vertical Y-axis shows the velocity of particles in each frame
(micron/sec); the horizontal X-axis shows the relative time during
the image sequence in which the particle was observed. (C)
Recovery of the signal was measured throughout the time
observed during 221 frames sequence using manual tracking of
ImageJ program. (D) HeLa cells were transfected with EGFP-
TRIM50, incubated for 30 min with TRITC-dextran, and
imaged using confocal fluorescence microscopy. EM immuno-
gold-labeled of a section corresponding to the area indicated by
the box in figure D.
(TIF)
Figure S3 TRIM50 interacts with beta tubulin. (A)
Endogenous TRIM50 colocalizes with polyubiquitinated proteins.
SH-SY5Y cells were stained with anti-TRIM50 antibody and with
FK2 antibody. Where indicated, the cells were treated with 25 mM
MG132 for 6 h. (B) HeLa cells expressing EGFP-TRIM50 were
stained with an anti-HDAC6 antibody. The cells were treated with
25 mM MG132 for 6 h (d–f). (C) The interaction between
TRIM50 and beta tubulin was assayed in HEK293 cells
transiently expressing FLAG-Tubb2b and EGFP-TRIM50. The
cell lysates were immunoprecipitated with anti-FLAG and
immunoblotted with anti-GFP antibody.
(TIF)
Figure S4 (A) TRIM50 E3-ubiquitin ligase activity is not
required for aggresome localization. MEF Trim502/2 cell
line was transfected with EGFP-Trim50DRING, treated with
25 mM MG132 for 6 h and stained with HDAC6 antibody (a–f).
(B) TRIM50 colocalizes with LC3. HeLa cells were transiently co-
transfected with HA-TRIM50 and DsRed-LC3 and stained with
anti-HA antibody. After 24h the cells were incubated with EBSS
medium for 2 h (d–f).
(TIF)
Figure S5 TRIM50 increases the insolubility of p62 and
HDAC6 into the aggresome. (A–B–C) TRIM50 promotes the
sequestration of p62 and HDAC6 in aggresome. Lysates from
FLAG-TRIM50#3 and FLAG#3 cell lines, treated with vehicle
(–) or with MG132 (+) were separated in detergent-soluble and
detergent insoluble fractions and immunoblotting with anti-FLAG
and anti-p62 antibodies. An example for p62 protein is depicted
(A). The asterisk shows the relative band of endogenous p62 of
previous immunoblotting. The relative level of soluble and
insoluble fractions was measured by quantification of the intensity
of p62 (B) and HDAC6 (C) bands of three indipendent
experiments.
(TIF)
Movie S1 EGFP-TRIM50 bodies movement. Movies
show a 110 frames sequence captured at 0.5 second
intervals.
(MOV)
Movie S2 FRAP analysis of TRIM50 cytoplasmic bodies.
Movies show a 224 frames sequence captured at 0.5
second intervals.
(MOV)
Table S1 Plasmids used in this study.
(DOC)
Table S2 TRIM50-associated proteins found ubiquiti-
nated and/or present within induced Aggresome.
(DOC)
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Figure 6. TRIM50-related aggresome and TRIM50 itself are partially degraded through the autophagy-lysosomal pathway. (A) FLAG-
TRIM50#3 cells were treated with 20 mM NH4Cl (A) and DMSO for a period of 10 hours. Cells were lysed at the indicated time after the initiation of
treatment and analysed by Western blotted using FLAG and GAPDH antibodies, respectively. The experiments were performed three times and
typical results are shown. (B) Curves describing TRIM50 levels as a function of time, based on the results in panel A. The density of each band was
determined by densitometer. The half-time of TRIM50 was determined by calculating the protein level at each time, normalized to the corresponding
GAPDH level, to the initial amount of TRIM50 protein and compared with the control cells treated with DMSO. (C) HeLa cells overexpressing EGFP-
TRIM50 were incubated in complete medium (a–c), EBSS (d–f), and DMEM supplemented with NH4Cl 20 mM for 2 h respectively and stained with an
anti-FK2 antibody.
doi:10.1371/journal.pone.0040440.g006
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